Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0001846478-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | 2025-08-12 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale | $86.53 | -5,873 | 84.0K | -7% | -$508.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | S | D | 5,873 | $86.53 | 84,024 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $86.50 to $86.79. The price reported above reflects the weighted average sales price. |